AIIMS Bathinda Launches Advanced Peritoneal Cancer Unit
The All India Institute of Medical Sciences in Bathinda has inaugurated a dedicated peritoneal cancer unit under its surgical oncology department. This state-of-the-art facility brings advanced treatment closer to patients suffering from complex abdominal malignancies across the region. Additionally, the initiative significantly expands regional access to specialized cytoreductive procedures.
Advancing Care with a Dedicated Peritoneal Cancer Unit
Managing primary and secondary peritoneal malignancies presents severe clinical hurdles for oncology teams. Therefore, establishing this dedicated unit provides a structured multidisciplinary approach to these aggressive diseases. The facility focuses on tumors spreading across the abdominal peritoneum and pelvic cavity. Consequently, patients with select colorectal, appendiceal, and ovarian cancers will receive prompt comprehensive evaluation. Furthermore, the unit delivers individualized care pathways designed to optimize surgical radicality through advanced training in surgical management.
Technological Precision with the RanD Performer 3 HIPEC System
The surgical oncology team utilizes the modern RanD Performer 3 system to deliver hyperthermic intraperitoneal chemotherapy. Specifically, this platform automates the circulation and precise heating of chemotherapeutic solutions directly within the peritoneal space. Temperature sensors maintain continuous thermal monitoring throughout the perfusion process. Moreover, targeted hyperthermia directly enhances drug cytotoxicity and increases tissue penetration depth. As a result, clinicians can eradicate microscopic residual disease while minimizing systemic side effects.
Comprehensive Protocols and Integrative Care Delivery
Cytoreductive surgery combined with heated intraperitoneal chemotherapy represents an intensive, complex intervention. However, strict patient selection criteria ensure optimal surgical safety and long-term therapeutic outcomes. AIIMS Bathinda offers this specialized service under expert clinical oncology supervision. In addition, the institute has introduced AYUSH healthcare options alongside conventional cancer treatments. These integrative therapies emphasize holistic recovery, patient wellness, and supportive care during recovery.
Frequently Asked Questions
Q1: What conditions does the new peritoneal cancer unit treat?
The unit treats peritoneal surface malignancies, including selected ovarian, colorectal, and appendiceal cancers that have spread to the peritoneum.
Q2: How does the HIPEC procedure benefit cancer patients?
HIPEC circulates heated chemotherapy directly into the abdomen immediately after cytoreductive surgery, targeting microscopic tumor cells with minimal systemic toxicity.
Q3: Why is continuous temperature monitoring vital during HIPEC?
Precise temperature monitoring maintains stable hyperthermia, which enhances chemotherapy penetration without damaging healthy surrounding tissues.
References
- AIIMS Bathinda sets up peritoneal cancer unit - ETHealthworld
- The Times of India - AIIMS Bathinda sets up peritoneal cancer unit
- Mayo Clinic - Hyperthermic intraperitoneal chemotherapy (HIPEC)
